Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.02M Buy
+43,628
New +$1.76M 0.01% 814
2025
Q1
Sell
-43,739
Closed -$721K 1453
2024
Q4
$721K Buy
+43,739
New +$619K ﹤0.01% 1045
2020
Q4
Sell
-29,488
Closed -$343K 1957
2020
Q3
$343K Sell
29,488
-38,306
-57% -$445K 0.01% 1216
2020
Q2
$626K Buy
+67,794
New +$608K 0.02% 968

Other funds holding AXGN

Michael Gelband's AXGN Position: Q2 2026 in Review

Michael Gelband opened a new position in Axogen (AXGN) in Q2 2026: 43,628 shares worth $2.02M. The stake represents 0.01% of the portfolio and ranks #814 among its holdings. This is a return to the name: Michael Gelband previously reported a position in AXGN as recently as Q4 2024.

Michael Gelband first reported a position in AXGN in Q2 2020 and has held it in 4 quarters since. 251 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Michael Gelband held 43,628 shares of Axogen worth $2.02M as of Q2 2026.
  • Axogen was a new Michael Gelband position in Q2 2026.
  • Axogen made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #814 holding.
  • Michael Gelband first reported a position in Axogen in Q2 2020 and has held it in 4 quarters since.
  • 251 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.